MXPA03002694A - Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis. - Google Patents
Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis.Info
- Publication number
- MXPA03002694A MXPA03002694A MXPA03002694A MXPA03002694A MXPA03002694A MX PA03002694 A MXPA03002694 A MX PA03002694A MX PA03002694 A MXPA03002694 A MX PA03002694A MX PA03002694 A MXPA03002694 A MX PA03002694A MX PA03002694 A MXPA03002694 A MX PA03002694A
- Authority
- MX
- Mexico
- Prior art keywords
- intermediates
- synthesis
- production
- phenylbenzylamine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000292264 | 2000-09-26 | ||
| PCT/JP2001/008338 WO2002026710A1 (fr) | 2000-09-26 | 2001-09-26 | Composes de 5-phenylbenzylamine, procede d'elaboration et intermediaires pour la synthese de ces composes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03002694A true MXPA03002694A (es) | 2003-06-24 |
Family
ID=18775227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03002694A MXPA03002694A (es) | 2000-09-26 | 2001-09-26 | Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7067535B2 (es) |
| EP (1) | EP1323713A4 (es) |
| KR (1) | KR20030036834A (es) |
| CN (1) | CN1466573A (es) |
| AU (2) | AU9223601A (es) |
| CA (1) | CA2422613A1 (es) |
| MX (1) | MXPA03002694A (es) |
| NZ (1) | NZ524673A (es) |
| WO (1) | WO2002026710A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1466904A4 (en) * | 2001-12-28 | 2005-12-14 | Takeda Pharmaceutical | BIARYL CONNECTION AND ITS USE |
| WO2003101964A1 (fr) * | 2002-05-31 | 2003-12-11 | Takeda Pharmaceutical Company Limited | Derive piperidine, procede de production, et utilisation |
| EP2129381A1 (en) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
| MX2011010058A (es) * | 2009-03-25 | 2011-10-11 | Abbott Lab | Compuestos antivirales y usos de los mismos. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232929A (en) | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| WO1992017449A1 (en) * | 1991-03-26 | 1992-10-15 | Pfizer Inc. | Stereoselective preparation of substituted piperidines |
| CZ280133B6 (cs) * | 1991-11-25 | 1995-11-15 | Eli Lilly And Company | Substituovaný fenylfenolleukotrienový antagonist a farmaceutický prostředek, který ho obsahuje |
| US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| EP0854720B1 (en) * | 1995-10-10 | 1999-08-04 | Pfizer Inc. | Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| JP2002534955A (ja) * | 1995-10-18 | 2002-10-15 | メルク エンド カンパニー インコーポレーテッド | シクロペンチルタキキニン受容体アンタゴニスト |
| PT780375E (pt) * | 1995-12-21 | 2002-12-31 | Pfizer | 3-¬(benzilo substituido em 5)amino|-2-phenilpiperidinas como antagonistas da substancia p |
| US5990125A (en) * | 1996-01-19 | 1999-11-23 | Pfizer Inc. | NK-1 receptor antagonists for the treatment of cancer |
| GB9723544D0 (en) * | 1997-11-07 | 1998-01-07 | Merck Sharp & Dohme | Therapeutic agents |
| DE10007939A1 (de) * | 2000-02-22 | 2001-08-23 | Clariant Gmbh | Verfahren zur Herstellung substituierter Benzylverbindungen und Toluolderivate |
-
2001
- 2001-09-26 MX MXPA03002694A patent/MXPA03002694A/es unknown
- 2001-09-26 WO PCT/JP2001/008338 patent/WO2002026710A1/ja active IP Right Grant
- 2001-09-26 EP EP01972483A patent/EP1323713A4/en not_active Withdrawn
- 2001-09-26 US US10/380,754 patent/US7067535B2/en not_active Expired - Fee Related
- 2001-09-26 CA CA002422613A patent/CA2422613A1/en not_active Abandoned
- 2001-09-26 CN CNA018163491A patent/CN1466573A/zh active Pending
- 2001-09-26 NZ NZ524673A patent/NZ524673A/en unknown
- 2001-09-26 AU AU9223601A patent/AU9223601A/xx active Pending
- 2001-09-26 AU AU2001292236A patent/AU2001292236B2/en not_active Ceased
- 2001-09-26 KR KR10-2003-7004292A patent/KR20030036834A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1466573A (zh) | 2004-01-07 |
| US20040097548A1 (en) | 2004-05-20 |
| NZ524673A (en) | 2005-08-26 |
| AU9223601A (en) | 2002-04-08 |
| WO2002026710A1 (fr) | 2002-04-04 |
| AU2001292236B2 (en) | 2005-01-27 |
| KR20030036834A (ko) | 2003-05-09 |
| EP1323713A4 (en) | 2005-01-26 |
| CA2422613A1 (en) | 2003-03-14 |
| US7067535B2 (en) | 2006-06-27 |
| EP1323713A1 (en) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX255774B (es) | Un proceso para la produccion de papel. | |
| HUP0302364A3 (en) | Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme | |
| HUP0103295A3 (en) | Process for producing citalopram | |
| MXPA03006322A (es) | Procedimiento mejorado para la sintesis de carbapenem. | |
| HUP0104566A3 (en) | Process for producing n-carboxi-anhidrides | |
| HK1049327A1 (zh) | 製備氨基二苯基胺的方法 | |
| EG23439A (en) | Olefins production process. | |
| ZA200108623B (en) | Process for preparing imidachloprid. | |
| AU9250401A (en) | New process for the production of oxabispidines | |
| IL162059A0 (en) | Process for the synthesis of -amino- chirally purealcohols | |
| ZA200106158B (en) | Method for production of catalyst. | |
| HK1040984A1 (zh) | 製備d，l-薄荷醇的方法 | |
| ZA200106159B (en) | Method for production of catalyst. | |
| MXPA03002926A (es) | Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina. | |
| ZA200104999B (en) | Method for the production of formaldehyde. | |
| MXPA03005569A (es) | PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO. | |
| MXPA03002694A (es) | Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis. | |
| MXPA01012693A (es) | Produccion mejorada de tequila. | |
| AU2001292236A1 (en) | 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis | |
| IL166374A0 (en) | Novel process for producing imidazoÄ1,2-bÜpyridazine derivative | |
| EG23229A (en) | Process for the production of olefins. | |
| HUP9901938A2 (en) | New process for producing 17-betha-hydroxy-17-alpha-methyl-2-oxa-5-alpha-androstan-3-on, as well as intermediate thereof | |
| AU8444201A (en) | Process for producing fluoroalkanol | |
| HUP0002005A3 (en) | Process for producing formaldehyde direct from methane | |
| HUP9901939A2 (en) | Process for producing a-nor-seco-steroide compounds, seco-indoxylidenecarboxilicacid derivetives as intermediates thereof |